Zoetis Inc. $ZTS Shares Sold by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC lowered its stake in shares of Zoetis Inc. (NYSE:ZTS) by 19.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,011 shares of the company’s stock after selling 13,314 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Zoetis were worth $8,203,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Zoetis by 0.8% during the 2nd quarter. Vanguard Group Inc. now owns 41,886,987 shares of the company’s stock worth $6,532,276,000 after purchasing an additional 330,823 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Zoetis by 0.9% during the second quarter. Geode Capital Management LLC now owns 11,081,301 shares of the company’s stock valued at $1,721,356,000 after buying an additional 95,294 shares during the period. Norges Bank purchased a new position in shares of Zoetis during the second quarter valued at approximately $809,491,000. Brown Advisory Inc. boosted its position in Zoetis by 5.7% during the second quarter. Brown Advisory Inc. now owns 4,659,371 shares of the company’s stock worth $726,629,000 after acquiring an additional 250,829 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in Zoetis by 113.0% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,761,920 shares of the company’s stock worth $586,671,000 after acquiring an additional 1,995,491 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ZTS. Morgan Stanley set a $160.00 price target on Zoetis in a research note on Thursday, December 18th. Piper Sandler reiterated a “neutral” rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a research report on Thursday. Stifel Nicolaus lowered their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a report on Tuesday, November 18th. KeyCorp initiated coverage on shares of Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating on the stock. Finally, Wall Street Zen raised shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Friday. Five equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $152.91.

Zoetis Stock Performance

Shares of Zoetis stock opened at $123.89 on Tuesday. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40. The firm’s 50-day simple moving average is $123.68 and its 200-day simple moving average is $137.91. The firm has a market cap of $54.60 billion, a PE ratio of 20.86, a price-to-earnings-growth ratio of 2.15 and a beta of 0.97.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The business had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.42 billion. During the same period last year, the firm earned $1.58 earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, January 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio is currently 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.